|
Author | MRI findings | Treatment | Outcome |
|
Farshad et al. | Spine: hyperintensity in the thoracic cord | Chronic glucocorticoids without pulse | Improvement in MRI findings |
Brain: hyperintensity within the right middle frontal gyrus | Methotrexate | Persistent neurological symptoms |
| IVIG | |
|
Jabbari et al. [2] | Spine: hyperintensity between T2 and conus medullaris with contrast enhancement | Pulse glucocorticoids without a taper/chronic glucocorticoids | Improvement in MRI findings |
Brain: unremarkable | IVIG | Resolution of neurological symptoms |
| Inpatient rehabilitation | |
|
Kumar et al. [3] | Spine: hyperintensity in the cervical and thoracic cord with contrast enhancement | Pulse glucocorticoids followed by chronic taper | Improvement in MRI findings |
Brain: contrast enhancement in the right basal forebrain | Infliximab | Persistent neurological symptoms |
IVIG | |
|
Danieli et al. [4] | Spine: hyperintensity in the cervical and thoracic cord with contrast enhancement | Pulse glucocorticoids without a taper/chronic glucocorticoids | No new lesions in MRI after treatment, unclear if resolved |
Brain: unremarkable | IVIG | Persistent neurological symptoms |
| Intramuscular immunoglobulin | |
|
Nguyen et al. [5] | Spine: was not obtained | Pulse glucocorticoids without a taper/chronic glucocorticoids | Improvement in MRI findings |
Brain: two enhancing lesions in left cerebellum as well as leptomeningeal enhancement | Rituximab | Improvement/near resolution of neurological symptoms |
| IVIG | |
|